Unenhanced Attenuation Assessment
Classic benign adrenal adenoma with characteristic washout
Did our AI summary help? Let us know.
Evidence-based calculations Used in clinical settings worldwide Regular monitoring recommended
Ready to run the numbers?
Why: This calculation helps assess important health parameters for clinical and personal wellness tracking.
How: Enter your values above and the calculator will apply validated formulas to compute your results.
Run the calculator when you are ready.
Typical Lipid-Rich Adenoma
Classic benign adrenal adenoma with characteristic washout
Click to load
Lipid-Poor Adenoma
Adenoma with higher unenhanced attenuation but good washout
Click to load
Suspicious Adrenal Lesion
Lesion with poor washout characteristics requiring further workup
Click to load
Possible Metastasis
Patient with known malignancy and new adrenal lesion
Click to load
Suspected Pheochromocytoma
Hypervascular lesion with clinical symptoms
Click to load
CT Attenuation Values
Additional Information
For informational purposes only — not medical advice. Consult a healthcare professional before acting on results.
🏥 Health Facts
— WHO
— CDC
What is Adrenal CT Washout Analysis?
Adrenal washout analysis is a specialized CT imaging technique that leverages the differential contrast enhancement and clearance patterns between benign adenomas and malignant lesions. Lipid-rich adenomas contain intracytoplasmic fat that causes rapid contrast material egress, while malignant tumors (metastases, adrenocortical carcinomas, pheochromocytomas) typically retain contrast longer due to their denser cellular architecture and neovascularization.
High Diagnostic Accuracy
Combined sensitivity of 88-96% and specificity of 87-96% makes washout analysis the gold standard for non-invasive adrenal mass characterization.
Evidence Base:
- Multiple prospective validation studies
- ACR Appropriateness Criteria endorsed
- International consensus guidelines
Three-Phase CT Protocol
Standardized imaging protocol captures unenhanced attenuation, peak contrast enhancement, and delayed washout characteristics.
Protocol Phases:
- Non-contrast (baseline)
- Portal venous (60-70 seconds)
- Delayed (10-15 minutes)
Clinical Decision Support
Guides management decisions for incidental adrenal masses, oncologic staging, and endocrine evaluation without invasive procedures.
Impact:
- Reduces unnecessary biopsies
- Optimizes oncology staging
- Cost-effective diagnosis
How CT Washout Analysis Works
CT washout analysis exploits the biological difference between benign adenomas and malignant lesions. Adenomas contain intracellular lipid droplets that create a sparse cellular matrix allowing rapid contrast egress, while malignant tumors have dense cellularity and abnormal vasculature that retains contrast longer.
🔬 Step-by-Step CT Protocol
Imaging Phases
- 1Non-contrast scan: Baseline attenuation measurement (≤10 HU = lipid-rich adenoma)
- 2IV contrast injection: 100-150 mL iodinated contrast at 2-4 mL/s
- 3Portal venous phase: Imaging at 60-70 seconds captures peak enhancement
- 4Delayed phase: Imaging at 10-15 minutes measures washout
- 5ROI placement: Largest homogeneous region avoiding calcifications/hemorrhage
Why This Method Works
- Adenomas have loose cellular architecture with intracellular lipid
- Malignant tumors have dense cellular matrix retaining contrast
- Quantitative thresholds provide objective classification
- Highly reproducible across institutions and equipment
⚠️ Technical Considerations
ROI Placement
- • Use largest homogeneous area
- • Avoid necrosis, hemorrhage, calcifications
- • Consistent placement across phases
Timing Critical
- • Enhanced: 60-70 seconds exactly
- • Delayed: 10 or 15 minutes
- • Consistent timing is essential
Pitfalls
- • Pheochromocytoma can mimic adenoma
- • Adrenocortical carcinoma variable
- • Hemorrhagic masses unreliable
When to Use This Calculator
Incidental Adrenal Mass
Found on CT for other reasons; need to characterize
Cancer Staging
Distinguish metastasis from incidental adenoma
Endocrine Workup
Evaluating functional adrenal lesions
Lipid-Poor Adenoma
When unenhanced attenuation is > 10 HU
Surgical Planning
Pre-operative characterization of adrenal masses
Follow-up Assessment
Monitoring indeterminate lesions over time
CT Washout Formulas
Absolute Percentage Washout (APW)
APW = [(Enhanced HU - Delayed HU) / (Enhanced HU - Unenhanced HU)] × 100Threshold: APW ≥ 60% suggests adenoma (sensitivity 88%, specificity 96%)
Relative Percentage Washout (RPW)
RPW = [(Enhanced HU - Delayed HU) / Enhanced HU] × 100Threshold: RPW ≥ 40% suggests adenoma (when unenhanced not available)
Unenhanced Attenuation Threshold
Unenhanced HU ≤ 10 = Lipid-rich adenoma (specificity > 98%)Most specific single criterion for adenoma diagnosis
Frequently Asked Questions
What if unenhanced HU is already ≤10?
An unenhanced attenuation ≤10 HU is highly specific (>98%) for lipid-rich adenoma. Washout analysis may not be necessary, though some centers perform it for confirmation or to document enhancement characteristics.
Can pheochromocytomas mimic adenomas?
Yes, some pheochromocytomas show rapid washout similar to adenomas. Clinical symptoms (episodic hypertension, palpitations, sweating) and biochemical testing (plasma metanephrines) are essential before any intervention.
What is the optimal delay time?
Standard protocol uses 15-minute delay, though 10-minute delays are also validated. The washout thresholds (APW ≥60%, RPW ≥40%) were established using 15-minute delay. Consistency within your institution is most important.
When should I use absolute vs relative washout?
Use absolute washout (APW) when all three phases are available - it has higher specificity. Use relative washout (RPW) when non-contrast imaging is unavailable. APW ≥60% or RPW ≥40% suggests adenoma.
What if washout is indeterminate?
Indeterminate results (APW 40-60% or RPW 30-40%) require additional workup. Consider MRI with chemical shift imaging, PET/CT for oncology patients, or short-interval follow-up imaging at 6-12 months.
Does lesion size affect washout accuracy?
Washout analysis is reliable for lesions ≥1 cm. Very small lesions may have partial volume averaging affecting measurements. Larger lesions (>4 cm) warrant more careful evaluation as adrenocortical carcinoma risk increases with size.
Related Calculators
Explore these related radiology and urology calculators for comprehensive clinical assessment.
Related Calculators
Albumin-Creatinine Ratio (ACR) Calculator
Calculate urine albumin-to-creatinine ratio for kidney disease screening and monitoring per KDIGO guidelines. Includes classification into A1, A2, and A3...
healthBladder Volume Calculator
Calculate bladder volume from ultrasound measurements using the prolate ellipsoid formula for post-void residual (PVR) and bladder capacity assessment.
healthBUN/Creatinine Ratio Calculator
Calculate the BUN to Creatinine ratio to differentiate prerenal from intrinsic renal causes of kidney dysfunction. Includes interpretation for prerenal...
healthCreatinine Clearance Calculator (Cockcroft-Gault)
Calculate creatinine clearance using the Cockcroft-Gault equation for drug dosing and kidney function assessment.
healthFENa Calculator (Fractional Excretion of Sodium)
Calculate FENa to differentiate prerenal azotemia from intrinsic AKI in patients with acute kidney injury.
healthFEUrea Calculator - Acute Kidney Injury Cause Differentiation
Calculate FEUrea for AKI differentiation in patients on diuretics where FENa may be unreliable.
health